Akso Health Group (AHG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 0.62 is considered Undervalued compared with the five-year average of 0.49. The fair price of Akso Health Group (AHG) is between 5.81 to 7.03 according to relative valuation method. Compared to the current price of 1.31 USD , Akso Health Group By Undervalued By 77.47%.

Relative Value

Fair Zone

5.81-7.03

Current Price：1.31

77.47%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Akso Health Group (AHG) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Akso Health Group (AHG) has a current Price-to-Book (P/B) ratio of 4.43. Compared to its 3-year average P/B ratio of 2.19, the current P/B ratio is approximately 102.15% higher. Relative to its 5-year average P/B ratio of 2.20, the current P/B ratio is about 101.24% higher. Akso Health Group (AHG) has a Forward Free Cash Flow (FCF) yield of approximately 0.12%. Compared to its 3-year average FCF yield of -6.73%, the current FCF yield is approximately -101.72% lower. Relative to its 5-year average FCF yield of -5.25%, the current FCF yield is about -102.21% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AHG competitors is 2.47, providing a benchmark for relative valuation. Akso Health Group Corp (AHG.O) exhibits a P/S ratio of 8.93, which is 260.84% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AHG increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AHG in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AHG currently overvalued or undervalued?

What is Akso Health Group (AHG) fair value?

AHG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Akso Health Group (AHG) is between 5.81 to 7.03 according to relative valuation method.

How does AHG's valuation metrics compare to the industry average?

The average P/S ratio for AHG's competitors is 2.47, providing a benchmark for relative valuation. Akso Health Group Corp (AHG) exhibits a P/S ratio of 8.93, which is 260.84% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Akso Health Group (AHG) as of Mar 03 2026?

As of Mar 03 2026, Akso Health Group (AHG) has a P/B ratio of 4.43. This indicates that the market values AHG at 4.43 times its book value.

What is the current FCF Yield for Akso Health Group (AHG) as of Mar 03 2026?

As of Mar 03 2026, Akso Health Group (AHG) has a FCF Yield of 0.12%. This means that for every dollar of Akso Health Group's market capitalization, the company generates 0.12 cents in free cash flow.

What is the current Forward P/E ratio for Akso Health Group (AHG) as of Mar 03 2026?

As of Mar 03 2026, Akso Health Group (AHG) has a Forward P/E ratio of 0.62. This means the market is willing to pay $0.62 for every dollar of Akso Health Group's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Akso Health Group (AHG) as of Mar 03 2026?

As of Mar 03 2026, Akso Health Group (AHG) has a Forward P/S ratio of 8.93. This means the market is valuing AHG at $8.93 for every dollar of expected revenue over the next 12 months.

AHG Valuation